NFKB1 and Alzheimer disease: Artemether treatment, at both low and high doses, significantly decreased glial compartment and the brain inflammatory markers IL-18 and NF-κB suggesting that the neurotherapeutic effect of Artemether in the 3xTg-AD mice may be contributed by anti-inflammatory and antiglia-mediated effects, in addition to its indirect antioxidant activity.